Atrium Innovations Inc (ATB.TO)

ATB.TO

About

Atrium Innovations Inc. (Atrium) is a Canada-based company engaged in the development, manufacturing, and commercialization of dietary supplements endorsed by health professionals. The Company owns more than 16 brands of products which are distributed mainly in the healthcare practitioner and health food and specialized store... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.50
Market Cap (Mil.):	$458.42
Shares Outstanding (Mil.):	31.32
Dividend:	--
Yield (%):	--

Financials

	ATB.TO	Industry	Sector
P/E (TTM):	12.33	32.01	32.18
EPS (TTM):	1.19	--	--
ROI:	4.77	19.61	18.91
ROE:	8.58	20.45	19.87

Latest News about ATB.TO

» More ATB.TO News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - ATRIUM INNOVATIONS INCORPORATION (ATB-T) Provider: Thomson Reuters Stock Report	$25.00 Buy
Atrium Innovations Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Wright Investors Service Comprehensive Report for Atrium Innovations Incorporation Provider: Wright Reports	$483.00 Buy
Atrium Innovations Inc (ATB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages Provider: Plunkett Research, Ltd.	$99.00 Buy
Atrium Innovations Inc. (ATB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.